Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF

Hippocampal overexpression of chordin protects against the chronic social defeat stress-induced depressive-like effects in mice

(2020) Cheng-Niu Wang et al.   BRAIN RESEARCH BULLETIN

miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression

(2020) Caifeng Liu et al.   CELL CYCLE

Molecular aspects of depression: A review from neurobiology to treatment

(2019) Gustavo Roberto Villas Boas et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1

(2019) Hong Liu et al.   PATHOLOGY RESEARCH AND PRACTICE

MiR-124 suppression in the prefrontal cortex reduces depression-like behavior in mice

(2019) Zhiwen Gu et al.   BIOSCIENCE REPORTS

Hippocampal PPARα is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice

(2018) Lu Song et al.   BRITISH JOURNAL OF PHARMACOLOGY

MiR-134 modulates chronic stress-induced structural plasticity and depression-like behaviors via downregulation of Limk1/cofilin signaling in rats

(2018) Cuiqin Fan et al.   NEUROPHARMACOLOGY

Transcription factor Runx1 is pro-neurogenic in adult hippocampal precursor cells

(2018) Hirokazu Fukui et al.   PLoS One

Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

(2018) Marion J. F. Levy et al.   PSYCHOPHARMACOLOGY

Hippocampal Salt-Inducible Kinase 2 Plays a Role in Depression via the CREB-Regulated Transcription Coactivator 1–cAMP Response Element Binding–Brain-Derived Neurotrophic Factor Pathway

(2018) Bo Jiang et al.   BIOLOGICAL PSYCHIATRY

The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology

(2018) Emily L. Belleau et al.   BIOLOGICAL PSYCHIATRY

Interleukin-10 inhibits neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway

(2017) Yan Zhu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson’s Disease

(2017) Xiao Chen et al.   Journal of Neuroimmune Pharmacology

Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients

(2017) Romain Colle et al.   NEUROPSYCHOBIOLOGY

Neural basis of major depressive disorder: Beyond monoamine hypothesis

(2017) Shuken Boku et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

The Mistreatment of Major Depressive Disorder

(2017) Joel Paris   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Neurobiology of Depression and Mechanism of Action of Depression Treatments

(2016) Pierre Blier   JOURNAL OF CLINICAL PSYCHIATRY

MicroRNAs in Cardiovascular Disease

(2016) Temo Barwari et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

BDNF – a key transducer of antidepressant effects

(2016) Carl Björkholm et al.   NEUROPHARMACOLOGY

Molecular neurobiology of major depressive disorder

(2016) Yong-Ku Kim   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway

(2016) Jiamin Mao et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Mapping gene regulatory circuitry of Pax6 during neurogenesis

(2016) Sudhir Thakurela et al.   Cell Discovery

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

(2015) John C McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Oxymatrine inhibits lipopolysaccharide-induced inflammation by down-regulating Toll-like receptor 4/nuclear factor-kappa B in macrophages

(2015) Yu Zhang et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro

(2015) Xuguang Zhai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

MiR-206, a Key Modulator of Skeletal Muscle Development and Disease

(2015) Guoda Ma et al.   International Journal of Biological Sciences

Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson’s disease

(2015) Jiaojiao Qin et al.   TOXICOLOGY LETTERS

microRNA-206 in Rat Medial Prefrontal Cortex Regulates BDNF Expression and Alcohol Drinking

(2014) J. D. Tapocik et al.   JOURNAL OF NEUROSCIENCE

MicroRNA Expression Profile and Functional Analysis Reveal that miR-206 is a Critical Novel Gene for the Expression of BDNF Induced by Ketamine

(2014) Xiaolin Yang et al.   NEUROMOLECULAR MEDICINE

MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer’s disease

(2014) Ning Tian et al.   Neuroscience Bulletin

miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model

(2012) Soon-Tae Lee et al.   ANNALS OF NEUROLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants

(2010) A. Baudry et al.   SCIENCE

MicroRNAs in Cancer

(2008) Yong Sun Lee et al.   Annual Review of Pathology-Mechanisms of Disease

Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease?

(2008) Sheue-Jane Hou et al.   MEDICAL HYPOTHESES

The molecular neurobiology of depression

(2008) Vaishnav Krishnan et al.   NATURE